Synthesis and evaluation of a series of C5'-substituted duocarmycin SA analogs.

@article{Robertson2010SynthesisAE,
  title={Synthesis and evaluation of a series of C5'-substituted duocarmycin SA analogs.},
  author={William M. Robertson and David B. Kastrinsky and Inkyu Hwang and Dale L. Boger},
  journal={Bioorganic \& medicinal chemistry letters},
  year={2010},
  volume={20 9},
  pages={
          2722-5
        }
}
The synthesis and evaluation of a key series of analogs of duocarmycin SA, bearing a single substituent at the C5' position of the DNA binding subunit, are described. 
The utilisation of Fmoc solid phase chemistry as a novel approach to the generation of duocarmycin analogues
The family is characterised by a common spirocyclopropylcyclohexadienone pharmacophore. This unusual structural motif is responsible for exceptionally efficient alkylation of adenine bases followingExpand
Discovery of an irreversible HCV NS5B polymerase inhibitor.
TLDR
Lead compound 2e was demonstrated to be potent, highly selective, and safe in in vitro and in vivo assays and its covalent binding to HCV NS5B polymerase enzyme was investigated by X-ray analysis. Expand
A fundamental relationship between hydrophobic properties and biological activity for the duocarmycin class of DNA-alkylating antitumor drugs: hydrophobic-binding-driven bonding.
TLDR
The results quantify the fundamental role played by the hydrophobic character of the compound in the expression of the biological activity of members in this class (driving the intrinsically reversible DNA alkylation reaction) and define the stunning magnitude of its effect. Expand
A Novel Depurination Methodology to Assess DNA Alkylation of Chloro-Bis-Seco-Cyclopropylbenzoindoles Allowed for Comparison of Minor-Groove Reactivity
TLDR
By applying acidic depurination analyses, this study has illustrated DNA adduct characteristics of novel bis-seco-CBIs with dominating mono-alkylation and provides an alternative method for evaluating DNA minor-groove alkylators. Expand
The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry–Biology Interface
  • D. Boger
  • Chemistry, Medicine
  • The Journal of organic chemistry
  • 2017
A Perspective of work in our laboratory on the examination of biologically active compounds, especially natural products, is presented. In the context of individual programs and along with a summaryExpand
Synthetic K⁺/Cl⁻-selective symporter across a phospholipid membrane.
TLDR
A series of transport experiments have demonstrated that the synthetic molecule functions as a mobile carrier of transporting salts via M(+)/Cl(-) symport, which exhibits a strong selectivity toward potassium chloride, while the carrier with a 15-azacrown-5 displays a moderate selectivity for sodium chloride. Expand

References

SHOWING 1-10 OF 94 REFERENCES
Synthesis and evaluation of a thio analogue of duocarmycin SA.
The design, synthesis, and preliminary evaluation of methyl 1,2,8,8a-tetrahydrocyclopropa[c]thieno[3,2-e]indol-4-one-6-carboxylate (CTI) derivatives are detailed representing a single atom change (NExpand
Critical Role of the Linking Amide in CC-1065 and the Duocarmycins: Implications on the Source of DNA Alkylation Catalysis
The preparation and evaluation of both enantiomers of 5 are described and it constitutes an analogue of CBI-TMI (4), the duocarmycins, and CC-1065 in which the amide linking the alkylation and DNA ...
An additional spirocyclization for duocarmycin SA.
A unique alternative to the p-spirocyclization for activation of compounds containing the duocarmycin SA alkylation subunit was established involving indole NH deprotonation and subsequentExpand
Examination of the role of the duocarmycin SA methoxy substituents: Identification of the minimum, fully potent DNA binding subunit
Abstract The preparation and examination of 4–7 revealed that (+)- 5 and (+)-duocarmycin SA were indistinguishable. In contrast, 6 and 7 exhibited properties more analogous to 4 illustrating that theExpand
Establishment of substituent effects in the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
TLDR
Substitution at the indole C5 position led to cytotoxic potency enhancements that can be >/=1000-fold providing simplified analogues containing a single DNA binding subunit that are more potent (IC(50)=2-3 pM) than CBI-TMI, duocarmycin SA, or CC-1065. Expand
Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
TLDR
Substitution at the indole C5 position led to cytotoxic potency enhancements that are > or =1000-fold, providing simplified analogues containing a single DNA binding subunit that are more potent (IC(50)=2-3 pM) than CBI-TMI, duocarmycin SA, or CC-1065. Expand
Synthesis and preliminary evaluation of agents incorporating the pharmacophore of the duocarmycin/pyrindamycin alkylation subunit: identification of the CC-1065/duocarmycin common pharmacophore
The synthesis of 7 (CI-TMI) incorporating the parent 1,2,7,7a-tetrahydrocycloprop[1,2-c]indol-4-one (CI) alkylation subunit of duocarmycin is described. The results of its comparative evaluation (inExpand
Synthesis and evaluation of duocarmycin SA analogs incorporating the methyl 1,2,8,8a-tetrahydrocyclopropa[c]oxazolo[2,3-e]indol-4-one-6-carboxylate (COI) alkylation subunit.
The design, synthesis and evaluation of methyl 1,2,8,8a-tetrahydrocyclopropa[c]oxazolo[2,3-e]indol-4-one-6-carboxylate (COI) derivatives are detailed representing analogs of duocarmycin SA containingExpand
Synthesis and evaluation of a series of C3-substituted CBI analogues of CC-1065 and the duocarmycins.
The synthesis and evaluation of a series of C3-substituted 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogues of the CC-1065 and duocarmycin alkylation subunits are detailed,Expand
Establishing the parabolic relationship between reactivity and activity for derivatives and analogues of the duocarmycin and CC-1065 alkylation subunits.
The preparation of a novel series of N-aryl CBI derivatives is detailed in which an aryl para substituent could be used to predictably modulate the reactivity of the resulting CC-1065/duocarmycinExpand
...
1
2
3
4
5
...